CCN3: A key growth regulator in Chronic Myeloid Leukaemia

Journal of Cell Communication and Signaling

Volumn 3, Issue 2, 2009, Pages 115-124

  McCallum, Lynn ^a   Lu, Wanhua ^a   Price, Susan ^a   Lazar, Noureddine ^b   Perbal, Bernard ^c   Irvine, Alexandra E ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c L'Oreal R and D   (United States)

Author keywords

Apoptosis; CCN3; Erk; Signalling

Indexed keywords

BCR ABL PROTEIN; GROWTH FACTOR; IMATINIB; MITOGEN ACTIVATED PROTEIN KINASE; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL GROWTH; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; GROWTH INHIBITION; GROWTH REGULATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 73549095505     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-009-0058-2     Document Type: Article

References (27)

1. K Balmanno SJ Cook 2009 Tumour cell survival signalling by the ERK1/2 pathway Cell Death Differ 3 368 377 10.1038/cdd.2008.148
2. E Beillard N Pallisgaard VH van der Velden W Bi R Dee E van der Schoot E Delabesse E Macintyre E Gottardi G Saglio, et al. 2003 Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program Leukemia 12 2474 2486 10.1038/sj.leu.2403136 (Pubitemid 38072587)
3. S Benini B Perbal D Zambelli MP Colombo MC Manara M Serra M Parenza V Martinez P Picci K Scotlandi 2005 In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type Oncogene 27 4349 4361 10.1038/sj.onc.1208620 (Pubitemid 40961758)
4. G Chevalier H Yeger C Martinerie M Laurent J Alami PN Schofield B Perbal 1998 novH: differential expression in developing kidney and Wilm's tumors Am J Pathol 6 1563 1575
5. BD Clarkson A Strife D Wisniewski C Lambek N Carpino 1997 New understanding of the pathogenesis of CML: a prototype of early neoplasia Leukemia 9 1404 1428 10.1038/sj.leu.2400751
6. MW Deininger JM Goldman JV Melo 2000 The molecular biology of chronic myeloid leukemia Blood 10 3343 3356
7. MW Deininger TL Holyoake 2005 Can we afford to let sleeping dogs lie? Blood 5 1840 1841 10.1182/blood-2004-12-4764 (Pubitemid 40731754)
8. D English BR Andersen 1974 Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque J Immunol Methods 3 249 252 10.1016/0022-1759(74)90109-4
9. CT Fu JF Bechberger MA Ozog B Perbal CC Naus 2004 CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression J Biol Chem 35 36943 36950 10.1074/jbc.M403952200 (Pubitemid 39129044)
10. M Fukunaga-Kalabis G Martinez SM Telson ZJ Liu K Balint I Juhasz DE Elder B Perbal M Herlyn 2007 Downregulation of CCN3 expression as a potential mechanism for melanoma progression Oncogene 27 2552 60 17968313 10.1038/sj.onc.1210896
11. J Gabert E Beillard VH van der Velden W Bi D Grimwade N Pallisgaard G Barbany G Cazzaniga JM Cayuela H Cave, et al. 2003 Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program Leukemia 12 2318 2357 10.1038/sj.leu.2403135 (Pubitemid 38072573)
12. Gellhaus A, Propson S, Gabriel HD, Gruemmer R, Duerig J, Klein-Hitpass BL, Maass K, Perbal B, Winterhager E (2003) NOV is associated with CX3 but not with CX0 and TRCX43 in human choriocarcinoma transfectants: evidence for potential growth-regulatory functions. Mol Pathol 56:75
13. HG Jorgensen TL Holyoake 2001 A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia Hematol Oncol 3 89 106
14. L Kumar 2006 Chronic myelogenous leukaemia (CML): an update Natl Med J India 5 255 263
15. Li WX, Martinerie C, Zumkeller W, Westphal M, Perbal B (1996) Differential expression of novH and CTGF in human glioma cell lines. Mol Pathol 91-97.
16. M Maillard B Cadot RY Ball K Sethia DR Edwards B Perbal R Tatoud 2001 Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues Mol Pathol 4 275 280 10.1136/mp.54.4.275 (Pubitemid 32730406)
17. MC Manara B Perbal S Benini R Strammiello V Cerisano S Perdichizzi M Serra A Astolfi F Bertoni J Alami, et al. 2002 The expression of ccn3(nov) gene in musculoskeletal tumors Am J Pathol 3 849 859
18. L McCallum AE Irvine 2009 CCN3-a key regulator of the hematopoietic compartment Blood Rev 2 79 85 10.1016/j.blre.2008.07.002
19. L McCallum S Price N Planque B Perbal A Pierce AD Whetton AE Irvine 2006 A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation Blood 5 1716 1723 10.1182/blood-2006- 04-016113 (Pubitemid 44316142)
20. Nowell PC, Hungerford D (1960) A minute chromosome in human chronic granulocytic leukaemia. Science 132:1497
21. B Perbal 2001 NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues Mol Pathol 2 57 79 10.1136/mp.54.2.57 (Pubitemid 32269998)
22. B Perbal M Zuntini D Zambelli M Serra M Sciandra L Cantiani E Lucarelli P Picci K Scotlandi 2008 Prognostic value of CCN3 in osteosarcoma Clin Cancer Res 3 701 709 10.1158/1078-0432.CCR-07-0806 (Pubitemid 351231150)
23. N Planque B Perbal 2003 A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis Cancer Cell Int 1 15 10.1186/1475-2867-3-15 (Pubitemid 38751070)
24. Rowley ID. (1973). A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 290-3.
25. Scotlandi K, Benini S, Manara MC, Cerisano V, Perdichizzi S, Strammiello R, Perbal B (2003). Biological role of NOVH in Ewings sarcoma cells. Mol Pathol 73
26. Sin WC, Bechberger JF, Rushlow WJ, Naus CC (2008) Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells. J Cell Biochem 103:1772-1782
27. S Wong ON Witte 2001 Modelling Philadelphia chromosome positive leukemias Oncogene 20 5644 5659 11607816 10.1038/sj.onc.1204638 1:CAS:528: DC%2BD3MXnt12gtb8%3D (Pubitemid 32928104)